CFDE Data Portal | Search RN7SKP116

	Label	Description
	RN7SKP116 Gene (Entity type)	ENSG00000252711 - RN7SK pseudogene 116
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Testis 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdrenalGland 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE146358 dopamine 5 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS

RN7SKP116

ENSG00000252711 - RN7SK pseudogene 116

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human up

A Gene Set from LINCS

GSE146358 dopamine 5 v 2 human up

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn

A Gene Set from LINCS

GSE146358 dopamine 3 v 2 human up

A Gene Set from LINCS

GTEx Testis 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx AdrenalGland 20-29 vs 50-59 Down

A Gene Set from GTEx

GSE146358 dopamine 5 v 7 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.